1.Raise awareness of targeting inflammation in DKD by Phosphodiesterases (PDEs).
2.Review the etiology of DKD.
3.Explore how PTX could be beneficial in patients unable to tolerate RAAS blockade.
Thursday, January 9, 2020 - 1:00pm to 2:00pm
5700 S Maryland Ave
Chicago, IL 60637
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Dr. David Leehey